BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5484340)

  • 1. [Significance of immunobiological observation of HCG levels in hydatidiform mole].
    Vácha K; Fabián M; Kopecný J
    Cesk Gynekol; 1970 Oct; 35(8):456-7. PubMed ID: 5484340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of human chorionic gonadotropin in normal pregnancy and in hydatiform mole. Immunologic method. Preliminary communication].
    Garcia Torres FZ; Villanueva Gasca A; Gracia Medrano P; Conde Manjarrez BI; Barrios Perez L; Martinez Godinez A; Rosas Arceo J
    Ginecol Obstet Mex; 1967 Aug; 22(130):947-59. PubMed ID: 5595964
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of immunological determination of the HCG-(human chorionic gonadotropin) level in hydatiform mole].
    Vácha K; Fabián M; Kopecný J
    Zentralbl Gynakol; 1971 Sep; 93(37):1289-92. PubMed ID: 5120124
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of placentotropin and choriogonadotropin concentration during early pregnancy and hydatidiform mole].
    Lajos S; Kóbor G; Vereczkey G; Szabó T; Arnold L; Kereszti J
    Orv Hetil; 1974 May; 115(18):1029-31. PubMed ID: 4825511
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity of molar pregnancies in the HL-A system.
    Lawler SD; Klouda PT; Bagshawe KD
    Am J Obstet Gynecol; 1974 Dec; 120(7):857-61. PubMed ID: 4429102
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed regression of huge theca lutein cysts monitored by serial sonograms and beta-HCG levels.
    Lupien C; Wagar H; Sauerbrei EE
    J Can Assoc Radiol; 1984 Mar; 35(1):70-2. PubMed ID: 6725375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and comparison of two forms of human chorionic gonadotropin from hydatidiform moles with low and high immunoreactivity.
    Imamura S; Imamichi S; Yamabe T; Ishiguro M
    Am J Obstet Gynecol; 1985 Jan; 151(1):136-41. PubMed ID: 3966497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologically determined chorionic gonadotrophin levels in Singapore women with hydatidiform mole.
    Fox FJ; Tow WS
    Obstet Gynecol; 1966 Jul; 28(1):73-85. PubMed ID: 5949635
    [No Abstract]   [Full Text] [Related]  

  • 12. [Directed observation of patients after abortion of a hydatidiform mole].
    Horálek F; Zenísek L; Fingerová H; Hadam I
    Cesk Gynekol; 1969 Mar; 34(3):164-6. PubMed ID: 5770727
    [No Abstract]   [Full Text] [Related]  

  • 13. Zone electrophoresis on starch grain of extracts of normal chorionic tissues, hydatidiform moles, urinary HCG and HMG preparations.
    Miyamoto U; Tojo S; Nishimura T
    J Jpn Obstet Gynecol Soc; 1968 Jan; 15(1):10-27. PubMed ID: 5662719
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of immunoreactive luteinizing hormone-releasing factor in hydatidiform mole as compared with normal human trophoblastic tissue.
    Osathanondh R; Elkind-Hirsch KE
    Placenta Suppl; 1981; 3():257-61. PubMed ID: 6763999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigenicity and biological activity of HCG].
    Kayama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1971 Mar; 23(3):191-200. PubMed ID: 5102809
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of human chorionic gonadotropin.
    Goldstein DP; Berkowitz RS; Kosasa TS
    Major Probl Obstet Gynecol; 1982; 14():64-97. PubMed ID: 6273663
    [No Abstract]   [Full Text] [Related]  

  • 19. Ampullary tubal hydatidiform mole treated with linear salpingotomy. A case report.
    Newcomer JR
    J Reprod Med; 1998 Oct; 43(10):913-5. PubMed ID: 9800677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of human chorionic gonadotrophin in the management of hydatidiform mole. (A review of the literature and a summary of the Singapore experience with 254 cases).
    Teoh ES
    Singapore Med J; 1969 Mar; 10(1):11-7. PubMed ID: 5816897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.